The aberrant expressions of nuclear matrix proteins during the apoptosis of human osteosarcoma cells

Anatomical Record

Volumn 293, Issue 5, 2010, Pages 813-820

  Zhao, Zhen Li ^a   Li, Qi Fu ^a   Zheng, Yan Bin ^a   Chen, Lan Ying ^b   Shi, Song Lin ^a   Jing, Guang Jun ^a  

^a XIAMEN UNIVERSITY   (China)

^b HENAN UNIVERSITY OF URBAN CONSTRUCTION   (China)

Author keywords

Apoptosis; Cell cycle; Cell morphology; Curcumin; Human osteosarcoma cell; Nuclear matrix protein

Indexed keywords

CURCUMIN; DNA FRAGMENT; NUCLEAR MATRIX PROTEIN; NUCLEOPHOSMIN; PROHIBITIN; VIMENTIN;

APOPTOSIS; ARTICLE; CELL AGGLUTINATION; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CHROMATIN; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROSCOPY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN; CURCUMIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; OSTEOSARCOMA; REPRESSOR PROTEINS; VIMENTIN;

EID: 77952612145     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21074     Document Type: Article

References (35)

1. Alvarez A, Lokeshwar VB. 2007. Bladder cancer biomarkers: current developments and future implementation. Curr Opin Urol 17:341-346. (Pubitemid 47344622)
2. Ammon HP, Wahl MA. 1991. Pharmacology of Curcuma longa. Planta Med 57:1-7.
3. Belichenko I, Morishima N, Separovic D. 2001. Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys 390:57-63. (Pubitemid 32493570)
4. Chen LY, Yang HB, Li QF, Song JY, Jing GJ. 2008. Apoptosis of human esophageal carcinoma cell line EC 9706 induced by curcumin. Prog Modern Biomed 8:1601-1604.
5. Danial NN, Korsmeyer SJ. 2004. Cell death: critical control points. Cell 116:205-219. (Pubitemid 38167313)
6. Dynlacht JR, Earles M, Henthorn J, Seno JD. 2000. Different patterns of DNA fragmentation and degradation of nuclear matrix proteins during apoptosis induced by radiation, hyperthermia or etoposide. Radiat Res 154:515-530.
7. Evan G, Littlewood T. 1998. A matter of life and cell death. Science 281:1317-1322.
8. Fellenberg J, Dechant MJ, Ewerbeck V, Mau H. 2003. Identification of drug-regulated genes in osteosarcoma cells. Int J Cancer 105:636-643. (Pubitemid 36687731)
9. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S. 2003. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 278:47853-47861. (Pubitemid 37523233)
10. Gotzmann J, Meissner M, Gerner C. 2000. The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis. Cell Death Differ 7:425-438. (Pubitemid 30255711)
11. Grisendi S, Mecucci C, Falini B, Pandolfi PP. 2006. Nucleophosmin and cancer. Nat Rev Cancer 6:493-505.
12. Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K. 2001. A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem 276:5992-5999. (Pubitemid 37385757)
13. Guo W, Healey JH. 2002. The relationship between osteoblastic phenotype and clinical issues in osteosarcoma. Chin J Orthopaed 22:410-413.
14. Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S. 1999. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93:152-161. (Pubitemid 29523391)
15. Hsu CY, Yung BY. 2000. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int J Cancer 88:392-400.
16. Hunot S, Flavell RA. 2001. Apoptosis. Death of a monopoly? Science 292:865-866.
17. Li P, Li QF, Shi SL, Liang Y. 2007. Regulation of bioactive peptides of oyster (BPO) on the cell cycle and gene expression of human gastric adenocarcinoma cell-line BGC-823. Chin J Mar Drugs 26:1-8.
18. Liang Y, Li QF, Zhang XY, Shi SL, Jing GJ. 2009. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid. J Cell Biochem 106:849-857.
19. Locklin RM, Federici E, Espina B, Hulley PA, Russell RG, Edwards CM. 2007. Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. Mol Cancer Ther 6:3219-3228.
20. Martelli AM, Bortul R, Bareggi R, Grill V, Narducci P, Zweyer M. 1999. Biochemical and morphological changes in the nuclear matrix prepared from apoptotic HL-60 cells: effect of different stabilizing procedures. J Cell Biochem 74:99-110. (Pubitemid 29270032)
21. Morishima N. 1999. Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstreamof Bcl-2 action. Genes Cells 4:401-414. (Pubitemid 29404782)
22. Otake Y, Mims A, Fernandes DJ. 2006. Merbarone induces activation of caspase-activated DNase and excision of chromosomal DNA loops from the nuclear matrix. Mol Pharmacol 69:1477-1485.
23. Peng X, Ye X, Wang S. 2004. Identification of novel immunogenic proteins of Shigella flexneri 2a by proteomic methodologies. Vaccine 22:2750-2756. (Pubitemid 38900650)
24. Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. 2004. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208:163-170. (Pubitemid 38624157)
25. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. 1997. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57:1301-1305. (Pubitemid 27152555)
26. Sato T, Saito H, Swensen J, Olifant A, Wood C, Danner D, Sakamoto T, Takita K, Kasumi F, Miki Y, Zhao Z-L, Li Q-F, Zheng Y-B, Chen L-Y, Shi S-L, Jing G-J. 1992. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 52:1643-1646.
27. Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M, Prigent SA, Manson MM. 2003. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 65:361-376. (Pubitemid 36084553)
28. Tabb MM, Sun A, Zhou C, Grun F, Errandi J, Romero K, Pham H, Inoue S, Mallick S, Lin M, Forman BM, Blumberg B. 2003. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 278:43919-43927. (Pubitemid 37377131)
29. Taimen P, Kallajoki M. 2003. NuMA and nuclear lamins behave differently in Fas-mediated apoptosis. J Cell Sci 116:571-583. (Pubitemid 36231295)
30. Tang J, Li QF. 2004. Poly (ADP-ribose) polymerase family. Chin J Cell Biol 26:551-554.
31. Tsutsui KM, Sano K, Tsutsui K. 2005. Dynamic view of the nuclear matrix. Acta Med Okayama 59:113-120.
32. van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B. 1997. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res 235:421-430. (Pubitemid 27398401)
33. Xie H, Yao L, Chen LJ, Hu WL. 2009. Mitochondrial mechanisms of apoptosis induced by artemisinin in human leukemia K562 Cells. Prog Modern Biomed 9:27-29.
34. Yang HB, Li QF, Li ZZ, Song JY, Liu YJ. 2009. Apoptosis of immortalized human epithelial cell Line HaCaT induced by curcumin. Acta Anat Sin 40:64-68.
35. Zhang G, Wang G, Wang S, Li Q, Ouyang G, Peng X. 2004. Applying proteomic methodologies to analyze the effect of hexamethylene bisacetamide (HMBA) on proliferation and differentiation of human gastric carcinoma BGC-823 cells. Int J Biochem Cell Biol 36:1613-1623. (Pubitemid 38625839)